BIKTARVY® (bictegravir 50/emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP

Please see full Prescribing Information, including BOXED WARNING, available at BiktarvyPI.com, in the pinned post, and at BiktarvyHCP.com. Please see Indication and Important Safety Information below in the pinned post and at https://www.biktarvyhcp.com/important-safety-information. This product information is intended for US Healthcare Professionals only. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc., at 1-800-445-3235 (option #3) or the FDA at 1-800-FDA-1088 or fda.gov/medwatch. BIKTARVY, the BIKTARVY Logo, FOR TODAY, TOMORROW, AND THE DAYS TO COME, GILEAD, the GILEAD Logo, and GSI are trademarks of Gilead Sciences, Inc., or its related companies. © 2024 Gilead Sciences, Inc. All rights reserved. US-BVYP-0985 08/24